Telix Pharmaceuticals Ltd - TLX

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$24.47M

QoQ value delta ($000)

+$16.02M (+189.52%)

Implied price effect (QoQ)

+26.31%

Total shares

2,569,698

QoQ shares delta

+1,448,605 (+129.21%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 39 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
FMR LLC	5,404	564,757	0.0%
Portolan Capital Management, LLC	5,179	541,267	0.28%
LAZARD ASSET MANAGEMENT LLC	2,774	289,917	0.0%
PORTLAND INVESTMENT COUNSEL INC.	2,547	266,200	0.82%
Private Advisor Group, LLC	1,669	174,415	0.01%
Integrated Wealth Concepts LLC	1,573	164,397	0.01%
Raiffeisen Bank International AG	1,164	130,000	0.02%
MORGAN STANLEY	1,114	116,440	0.0%
JPMORGAN CHASE & CO	513	57,348	0.0%
Mariner, LLC	415	43,446	0.0%
Schonfeld Strategic Advisors LLC	333	34,873	0.0%
Vanguard Personalized Indexing Management, LLC	318	33,253	0.0%
UBS Group AG	309	32,300	0.0%
XTX Topco Ltd	248	26,007	0.0%
IHT Wealth Management, LLC	239	25,035	0.01%
Vident Advisory, LLC	159	16,653	0.0%
XY Capital Ltd	120	12,552	0.12%
BNP PARIBAS FINANCIAL MARKETS	114	12,000	0.0%
BANK OF AMERICA CORP /DE/	95	10,031	0.0%
RHUMBLINE ADVISERS	93	9,823	0.0%
NewEdge Advisors, LLC	18	1,920	0.0%
EverSource Wealth Advisors, LLC	17	1,832	0.0%
CWM, LLC	13	1,425	0.0%
Arax Advisory Partners	9	125	0.0%
Larson Financial Group LLC	8	899	0.0%